LABU:ARCA-Direxion Daily S&P Biotech Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 114.7

Change

+1.26 (+1.11)%

Market Cap

USD 0.28B

Volume

1.46M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is designed to measure the performance of a sub-industry or group of sub-industries determined based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.05%

Management Expense Ratio: 1.14 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

+2.79 (+4.84%)

USD 10.55B
QLD ProShares Ultra QQQ 0.95 %

+1.67 (+1.62%)

USD 7.01B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+24.02 (+4.83%)

USD 6.16B
SSO ProShares Ultra S&P500 0.90 %

+0.71 (+0.84%)

USD 5.52B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

+1.90 (+1.27%)

USD 4.69B
TECL Direxion Daily Technology Bull.. 1.17 %

+4.04 (+4.00%)

USD 3.65B
UPRO ProShares UltraPro S&P500 0.92 %

+0.99 (+1.26%)

USD 3.51B
FAS Direxion Daily Financial Bull .. 1.04 %

-0.53 (-0.51%)

USD 2.16B
TNA Direxion Daily Small Cap Bull .. 1.10 %

-0.02 (-0.06%)

USD 1.99B
USD ProShares Ultra Semiconductors 0.95 %

+8.97 (+6.38%)

USD 1.27B

ETFs Containing LABU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.96% 25% F 23% F
Dividend Return 0.25% 15% F 5% F
Total Return -5.71% 25% F 21% F
Trailing 12 Months  
Capital Gain -1.97% 22% F 30% F
Dividend Return 0.48% 11% F 5% F
Total Return -1.49% 21% F 25% F
Trailing 5 Years  
Capital Gain -88.99% 3% F 3% F
Dividend Return 0.10% 2% F 1% F
Total Return -88.89% 3% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain 8.31% 37% F 67% D+
Dividend Return 8.38% 36% F 61% D-
Total Return 0.07% 5% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 352.58% 12% F 2% F
Risk Adjusted Return 2.38% 19% F 31% F
Market Capitalization 0.28B 85% B 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.